Cardiff Oncology, Inc. - 8-K Filing
Cardiff Oncology settles litigation with Nerviano Medical Sciences, amending their license agreement for onvansertib (Items: 1.01 Entry into a Material Definitive Agreement, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits (d) Exhibits)
Tickers: $CRDF